Actions of progesterone on uterine immunosuppression and endometrial gland development in the uterine gland knockout (UGKO) ewe.
In ewes, the uterine gland knockout (UGKO) phenotype is caused by neonatal exposure to norgestomet to arrest uterine gland development and produce an adult which has a uterus characterized by the lack of endometrial glands. Since endometrial glands in the sheep produce the lymphocyte-inhibitory protein, ovine uterine serpin (OvUS), an experiment was conducted with ewes of the UGKO phenotype to evaluate whether the inhibitory actions of progesterone on tissue rejection responses in utero are dependent upon the presence of endometrial glands. Control and UGKO ewes were ovariectomized and subsequently treated with either 100 mg/day progesterone or corn oil vehicle for 30 days. An autograft and allograft of skin were then placed in each uterine lumen and treatments were continued for an additional 30 days before grafts were examined for survival. All autografts survived and had a healthy appearance after histological analysis. Allografts were generally rejected in ewes treated with vehicle but were present for hormone-treated ewes, regardless of uterine phenotype. Analysis of the histoarchitecture and protein synthetic capacity of the uterus revealed that progesterone induced differentiation of endometrial glands and synthesis and secretion of OvUS in UGKO ewes. The UGKO ewes had reduced density of CD45R+ lymphocytes in the endometrial epithelium and there was a tendency for progesterone to reduce this effect in luminal epithelium. Taken together, results confirm the actions of progesterone to inhibit graft rejection response in utero. Responses of UGKO ewes to progesterone indicate that the hormone can induce de novo development and differentiation of endometrial glands, at least when skin grafts are in the uterus.
Padua
Maria B
MB
Department of Animal Sciences, University of Florida, Gainesville, Florida 32611-0910, USA.
Tekin
Saban
S
Spencer
Thomas E
TE
Hansen
Peter J
PJ
D000818:Animals; D004717:Endometrium / Q000276:immunology*; D005088:Exocrine Glands / Q000276:immunology*; D005260:Female; D006085:Graft Survival / Q000187:drug effects*; D007165:Immunosuppression Therapy; D011374:Progesterone / Q000008:administration & dosage*; D034561:Sheep, Domestic / Q000235:genetics / Q000276:immunology; D016038:Skin Transplantation; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
D011374:Progesterone